Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 293 followers
Latest posts
Last updated about 10 hours ago
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 20, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 11, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation: 25/08/2025, Revision: 1, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Yeytuo, lenacapavir, Date of authorisation...
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 8, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation...
Human medicines European public assessment report (EPAR): Fluad Tetra, influenza vaccine (surface antigen, inactivated, adjuvanted), Date of authorisation: 20/05/2020, Revision: 10, Status: Withdrawn
about 13 hours ago
Human medicines European public assessment report (EPAR): Fluad Tetra, influenza vaccine (surface...
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation: 18/07/2025, Revision: 1, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation: 11/03/2010, Revision: 39, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Revolade, eltrombopag, Date of authorisation...
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation: 25/04/2022, Revision: 8, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Vydura, rimegepant, Date of authorisation...
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 3, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation...
Human medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation: 01/09/2010, Revision: 22, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation...
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 23, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation...
Human medicines European public assessment report (EPAR): DaTSCAN, ioflupane (123l), Date of authorisation: 27/07/2000, Revision: 26, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): DaTSCAN, ioflupane (123l), Date of...